Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Science
Bernadette B. Tixon

Pancreatic Cancer Drug Rasonque Shows Early Promise Against RAS-Mutated Lung Cancer Too

Rasonque (daraxonrasib) were approved for pancreatic cancer in August before showing early promise against lung tumours too (Credit: Julie Viken/Pexels)

A drug approved for pancreatic cancer just a week ago is already showing signs it could help treat lung cancer, the world's leading cause of cancer death.

Early trial results published in the New England Journal of Medicine found that tumours shrank in more than 30 per cent of lung cancer patients given the drug, called daraxonrasib (brand name Rasonque).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.